Autolus hosts ALL Business investor event; presentation lacks specific financial data

Autolus Therapeutics plc

Virtual investor event held on April 8, 2026, titled 'Spotlight on the Acute Lymphoblastic Leukemia (ALL) Business'.
Presentation materials posted on company website and attached as Exhibit 99.1 to the 8-K filing.
Filed under Regulation FD; only cover slide and disclaimer visible in the provided exhibit text.
No new material financial, operational, or pipeline details are discernible from the filing content.
Event appears to be a strategic update; no guidance or quantitative disclosures included.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.